Patient Recruitment/Retention Featured Articles

  1. How Patient-Centric Approaches Are Shaping The Future Of CGT 8/6/2024

    Emily Whitehead’s CAR-T cell therapy journey highlights the power of patient engagement in cell and gene therapies. Discover how her story and advocacy drive a patient-centric approach in innovative treatments.

  2. Want More Diverse Enrollment? Slow Down And Listen To Patients 8/2/2024

    Getting more diverse patients enrolled in clinical trials isn't an easy task, but Teri Crumb, MSN, RN, CCRC says it could be as simple as taking the time to understand and then meet patients' needs.

  3. Government Contract Advances Walgreens In Clinical Space 8/1/2024

    Walgreen’s new $25 million deal with BARDA (Biomedical Advanced Research and Development Authority) is a huge win for the pharmacy chain. John Campbell, head of DCTs at Walgreens, explains the ins and outs of the study and what could be next for the company regarding its clinical trials division.

  4. 5 Drivers Of Patient Financial Toxicity — And 10 Tips To Address Them 7/30/2024

    Clinical research administrator Tina Bowdish points to five causes of financial toxicity for patients participating in clinical trials and offers 10 ways to address them.

  5. Siteless DCTs Are Real … And Happening Now 6/20/2024

    Siteless DCTs (decentralized trials) are rare, but Praxis Precision Medicines is running one now for patients with essential tremor (ET). Marcio Souza, PharmD, the company’s president and CEO, talks about why they chose this model and the surprising speed at which it is progressing.

  6. 4 Tips For Diverse Recruiting In Dermatologic Clinical Trials 6/17/2024

    Diverse patient recruitment in dermatologic clinical trials is imperative for addressing health disparities and advancing equitable care. Alain Michon, MD defines those disparities, describes why they exist, and offers four tips for offering underserved patients better care.

  7. A Couple's Plan To Revamp Poland's Clinical Trial System 6/11/2024

    Hanna and Artur Preus collected and analyzed 3,208 questionnaires from patients, pharma companies, CROs, site staff, and private companies to identify the shortcomings in the Polish clinical trials system and then make recommendations on how to improve it.

  8. How DIA Continues To Enhance Its Global Annual Meeting 6/3/2024

    After his first year at the helm of DIA, president and CEO, Marwan Fathallah, talks about some of the key changes and highlights at this year’s global annual meeting. 

  9. Medical Affairs: Unlocking Insights To Drive Innovation, Access, And Value 6/3/2024

    Medical affairs (MA) professionals are playing an increasingly dynamic, strategic role across the innovation life cycle. Astellas Pharma Executive Vice President, Head Medical Affairs Shontelle Dodson explains.

  10. 5 Strategies To Increase Enrollment Of Black Women In Clinical Trials 5/30/2024

    Research has shown 80% of Black women are interested in clinical trials, but enrollment numbers don't match up. GCI Health's Kianta Key addresses barriers and offers five ways to increase the women's presence in clinical trials.